Gesuelli G C, Sartelli M, Berbellini A, Brianzoni E, Simonacci M, Sigona M
Divisione di Chirurgia Generale, Ospedale Generale Provinciale, Macerata.
Minerva Chir. 2000 Jul-Aug;55(7-8):513-6.
The purpose of this study is to emphasize the usefulness of combined intraoperative gamma-detecting-probe (C-Trak) and blue dye guided research of sentinel nodes (SN) in the treatment of cutaneous melanoma.
At the Department of General Surgery of Macerata Hospital, after informed consent, 22 consecutive patients (10 males and 12 females) with mean age 53 years (20-78 years) affected by histologically proved cutaneous malignant melanoma in stage I (TC, ultrasonography and bone scintigraphy) were studied by dynamic lymphoscintigraphy with 10.8-22.2 MBq of 99mTc albumin microcolloids 18-22 hours before surgery and by intradermal injection of blue dye at induction of anaesthesia. Intraoperative mapping technique to localize SN has been done by using a combination of a vital blue dye and a radioactive tracer.
A total of 42 SN were identified. Micrometastases were found in 2 (9.1%) patients; 13 SN were well-coloured (31%), 23 SN were poorly-coloured (55%), and 6 SN were not coloured (14%). Overall localization with blue dye was 86%. All SN were radiolabeled, but identification with gamma detecting probe was possible only in 41 cases (95%). Combined techniques was effective in 100% of cases.
Combined use of radiocolloids and blue dye is the gold standard for correct identification and biopsy of SN with 100% of favourable results. The technique is simple, fast and effective and permits to select the patients that need other surgical and oncologic procedures.
本研究旨在强调术中联合γ探测探头(C-Trak)和蓝色染料引导前哨淋巴结(SN)研究在皮肤黑色素瘤治疗中的实用性。
在马切拉塔医院普通外科,经患者知情同意后,对22例连续患者(10例男性和12例女性)进行研究,这些患者平均年龄53岁(20 - 78岁),经组织学证实为I期皮肤恶性黑色素瘤(TC,超声检查和骨闪烁显像)。术前18 - 22小时用10.8 - 22.2 MBq的99mTc白蛋白微胶体进行动态淋巴闪烁显像,并在麻醉诱导时皮内注射蓝色染料。通过使用活性蓝色染料和放射性示踪剂的组合进行术中定位SN的技术。
共识别出42个SN。在2例(9.1%)患者中发现微转移;13个SN染色良好(31%),23个SN染色不佳(55%),6个SN未染色(14%)。蓝色染料总体定位率为86%。所有SN均被放射性标记,但仅在41例(95%)中能用γ探测探头识别。联合技术在100%的病例中有效。
放射性胶体和蓝色染料的联合使用是正确识别和活检SN的金标准,效果良好率达100%。该技术简单、快速且有效,能够筛选出需要其他手术和肿瘤治疗程序的患者。